Position in LLY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$33,100,672
+$7,185,233 QoQ
Shares Held
27,597
-2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
4.23%
of 13F equity value
Holder Rank
#676
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. LLY ranks #1 (40.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,100,672 | 27,597 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $25,915,439 | 28,176 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $31,303,281 | 29,128 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $23,110,507 | 30,289 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $24,108,524 | 30,927 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $27,313,669 | 33,071 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $25,684,440 | 33,270 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $27,448,192 | 30,982 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $28,410,823 | 31,380 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $24,003,955 | 30,855 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $18,628,957 | 31,958 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $18,685,141 | 34,787 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $15,768,983 | 33,624 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $12,577,757 | 36,625 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $13,679,123 | 37,391 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $12,772,971 | 39,502 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $13,095,649 | 40,390 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $11,740,597 | 40,998 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $11,231,933 | 40,663 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $9,568,241 | 41,412 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $8,156,933 | 43,662 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $7,365,306 | 43,623 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,100,939 | 41,217 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $6,748,782 | 41,106 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $5,561,978 | 40,095 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||